In Brief
J&J agrees to settle shareholder complaint; USPlabs destroys DMAA product; Acura strengthens Nexafed; Abbott nutrition sales drive growth; Re-launches drive Novartis OTC rebound; more news In Brief.
J&J agrees to settle shareholder complaint; USPlabs destroys DMAA product; Acura strengthens Nexafed; Abbott nutrition sales drive growth; Re-launches drive Novartis OTC rebound; more news In Brief.